| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0920-1211(02)00010-4 |
| P698 | PubMed publication ID | 11948006 |
| P2093 | author name string | Giuseppe Capovilla | |
| Pierangelo Veggiotti | |||
| Giangennaro Coppola | |||
| Antonino Romeo | |||
| Antonio Pascotto | |||
| Gaetano Tortorella | |||
| Maria Spanò | |||
| Alessandra Montagnini | |||
| Maurizio Viri | |||
| P2860 | cites work | A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children. Topiramate YP Study Group. | Q52034189 |
| Topiramate for intractable childhood epilepsy. | Q52178428 | ||
| Topiramate in intractable childhood onset epilepsy--a cautionary note | Q73186451 | ||
| Neurotrophin-3 levels in cerebrospinal fluid from children with bacterial meningitis, viral meningitis, or encephalitis | Q73370294 | ||
| Topiramate in the treatment of severe myoclonic epilepsy in infancy | Q73405756 | ||
| Topiramate for drug-resistant epilepsies | Q73507116 | ||
| Clinical experiences with topiramate in children with intractable epilepsy | Q78169383 | ||
| Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy | Q28273764 | ||
| Paroxysmal tonic upgaze: physiopathological considerations in three additional cases | Q33145223 | ||
| A double-blind, randomized trial of topiramate in Lennox-Gastaut syndrome. Topiramate YL Study Group | Q33865133 | ||
| Efficacy and tolerability of topiramate in childhood and adolescent epilepsy: a clinical experience. | Q33939082 | ||
| A pilot study of topiramate in the treatment of infantile spasms | Q34484322 | ||
| Topiramate in refractory partial-onset seizures in children, adolescents and young adults: a multicentric open trial | Q43542347 | ||
| P433 | issue | 1 | |
| P921 | main subject | multicenter clinical trial | Q6934595 |
| myoclonic epilepsy | Q11883686 | ||
| Italy | Q38 | ||
| infancy stage | Q49257364 | ||
| P304 | page(s) | 45-48 | |
| P577 | publication date | 2002-03-01 | |
| P1433 | published in | Epilepsy Research | Q15746405 |
| P1476 | title | Topiramate as add-on drug in severe myoclonic epilepsy in infancy: an Italian multicenter open trial | |
| P478 | volume | 49 |
| Q37883054 | "Epileptic encephalopathy" of infancy and childhood: electro-clinical pictures and recent understandings |
| Q24202411 | Antiepileptic drugs for the treatment of severe myoclonic epilepsy in infancy |
| Q36576250 | Computational models of neuronal biophysics and the characterization of potential neuropharmacological targets |
| Q57468371 | Current Treatment Strategies and Future Treatment Options for Dravet Syndrome |
| Q37866832 | Current therapeutic procedures in Dravet syndrome. |
| Q54600675 | De-novo mutations of the sodium channel gene SCN1A in alleged vaccine encephalopathy: a retrospective study. |
| Q37866828 | Dravet syndrome history |
| Q48703820 | Dynamic changes of depolarizing GABA in a computational model of epileptogenic brain: Insight for Dravet syndrome |
| Q42678204 | Efficacy and safety of topiramate in refractory epilepsy of childhood: long-term follow-up study. |
| Q36302381 | Epileptic encephalopathies in adults and childhood |
| Q51244210 | Evaluation of health-care utilization in patients with Dravet syndrome and on adjunctive treatment with stiripentol and clobazam. |
| Q36925220 | Genetic variations and associated pathophysiology in the management of epilepsy. |
| Q91856722 | Incidence and phenotypes of childhood-onset genetic epilepsies: a prospective population-based national cohort |
| Q36945018 | Increased propensity for calcium phosphate kidney stones with topiramate use. |
| Q26776222 | Low-dose fenfluramine in the treatment of neurologic disorders: experience in Dravet syndrome |
| Q33887963 | Metabolic disturbances and renal stone promotion on treatment with topiramate: a systematic review |
| Q30399331 | Mozart K.448 acts as a potential add-on therapy in children with refractory epilepsy. |
| Q30384106 | Mozart's music in children with epilepsy. |
| Q36344246 | Neonatal epilepsy syndromes and generalized epilepsy with febrile seizures plus (GEFS+). |
| Q33919910 | Nephrolithiasis in topiramate users |
| Q38080786 | Neurogenetic disorders and treatment of associated seizures |
| Q35953476 | Pharmacotherapy for Dravet Syndrome |
| Q36372571 | Practitioner review: use of antiepileptic drugs in children |
| Q36816967 | Prevalence and spot urine risk factors for renal stones in children taking topiramate |
| Q90248151 | Recent Advances in the Drug Treatment of Dravet Syndrome |
| Q28585126 | Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy |
| Q84682466 | Retrospective analysis of the effectiveness of first-line antiepileptic drugs for generalized onset and unclassified epileptic seizures in Chinese children |
| Q36507532 | Role of valproate across the ages. Treatment of epilepsy in children |
| Q37985147 | SCN1A mutations in Dravet syndrome: impact of interneuron dysfunction on neural networks and cognitive outcome |
| Q40521728 | Severe myoclonic epilepsy in infancy: toward an optimal treatment |
| Q28261980 | Stiripentol |
| Q38757727 | Stiripentol and vigabatrin current roles in the treatment of epilepsy |
| Q38121171 | Stiripentol in Dravet syndrome: results of a retrospective U.S. study. |
| Q36697489 | Stiripentol. |
| Q51342135 | Successful use of fenfluramine as an add-on treatment for Dravet syndrome. |
| Q36776559 | Synergistic GABA-enhancing therapy against seizures in a mouse model of Dravet syndrome |
| Q36366703 | The epileptic encephalopathies of infancy and childhood. |
| Q29013852 | The pharmacologic treatment of Dravet syndrome |
| Q40328281 | Therapy for hyperthermia-induced seizures in Scn1a mutant rats |
| Q36429751 | Topiramate and its clinical applications in epilepsy |
| Q44879175 | Topiramate efficacy in an infant with partial seizures refractory to conventional antiepileptic drugs |
| Q46930688 | Topiramate in children and adolescents with epilepsy and mental retardation: a prospective study on behavior and cognitive effects |
| Q37129817 | Topiramate in the treatment of partial and generalized epilepsy |
| Q45127650 | Topiramate pharmacokinetics in children with epilepsy aged from 6 months to 4 years |
| Q44403272 | Topiramate: efficacy and tolerability in children according to epilepsy syndromes. |
| Q51732930 | Treatment Strategies for Dravet Syndrome. |
| Q28285293 | Treatment of epileptic encephalopathies |
| Q34986819 | Treatment options for epileptic myoclonus and epilepsy syndromes associated with myoclonus |
Search more.